Browse local and international markets online. Find the latest news from world leading business publication
Orum Therapeutics Announces U.S. FDA Clearance of an IND Application for ORM-1153, a Novel CD123-GSPT1 Degrader-Antibody Conjugate
Company to host a conference call to discuss the ORM-1153 IND clearance and provide a …